Enbrel 25 mg solution for injection in pre-filled syringe

DRUG4 trials

Sponsors

Giannina Gaslini Institute For Scientific Hospitalization And Care, IRCCS Istituto Giannina Gaslini, Duke Clinical Research Institute, Sint Maartenskliniek Stichting

Conditions

Juvenile Idiopathic ArthritisJuvenile idiopathic arthritisRheumatoid arthritisjuvenile idiopathic arthritis

Phase 3

Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS

Not yet recruitingCTIS2023-505051-43-00

Giannina Gaslini Institute For Scientific Hospitalization And Carejuvenile idiopathic arthritis

Target: 260Updated: 2025-09-30

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)

Not yet recruitingCTIS2025-520923-25-00

Duke Clinical Research InstituteJuvenile Idiopathic Arthritis

Target: 30Updated: 2026-02-11

Phase 4

Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.

RecruitingCTIS2024-514732-24-00

IRCCS Istituto Giannina GasliniJuvenile idiopathic arthritis

Start: 2025-04-28Target: 328Updated: 2025-08-26

DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial

Not yet recruitingCTIS2026-525316-33-00

Sint Maartenskliniek StichtingRheumatoid arthritis

Target: 202Updated: 2026-06-09